Close
Nordic 9Nordic 9

D-Sight (private company)

Spain
See something wrong or missing? Let us know
Offices:Barcelona
Industry:BiotechHealth services
Business model:B2B

D-Sight is a spin-off of the Vall d'Hebron Institute of Research (VHIR) in Spain, whose objective is the research and development of innovative therapeutic strategies for the treatment of diabetic retinopathy and other neurodegenerative diseases of the retina, such as glaucoma.

Investors: we tracked 1 investor

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 1.1M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to D-Sight

Name Criteria
France AbolerIS Pharma
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Norway APIM Therapeutics
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain AptaTargets
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Aquilón CyL
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Sweden Athera
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden AttgeNO
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Switzerland Bionomous
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Cebiotex
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Sweden Celluminova
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: < 1M USD
Denmark Oui
47%
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Top